All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ESTA / Establishment Labs Holdings Inc.
|
|
|
|
|
|
|
|
LHCG / LHC Group Inc
|
|
|
|
|
|
|
|
RETA / Reata Pharmaceuticals Inc - Class A Call
|
|
|
|
|
|
|
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
MRNA / Moderna, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
BEAM / Beam Therapeutics Inc. Put
|
|
|
|
|
|
|
|
ARK ETF TR
/ PUT Put (00214Q952) |
|
|
|
|
|
|
|
SPDR SER TR
/ PUT Put (78464A950) |
|
|
|
|
|
|
|
TWST / Twist Bioscience Corporation Put
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
TBIO / Telesis Bio, Inc.
|
|
|
|
|
|
|
|
BTAI / BioXcel Therapeutics, Inc.
|
|
|
|
|
|
|
|
EVFM / Evofem Biosciences, Inc.
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
US0153511094 / Alexion Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
OEF / iShares Trust - iShares S&P 100 ETF Put
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
US85789A1051 / STEALTH BIOTHERAPEUTICS CORP ADR
|
|
|
|
|
|
|
|
AMRX / Amneal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VCYT / Veracyte, Inc. Put
|
|
|
|
|
|
|
|
CI / The Cigna Group
|
|
|
|
|
|
|
|
US0906721065 / BioTelemetry, Inc.
|
|
|
|
|
|
|
|
INOV / Innovator ETFs Trust - Innovator International Developed Power Buffer ETF - November
|
|
|
|
|
|
|
|
IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
CHNG / Change Healthcare Inc
|
|
|
|
|
|
|
|
MGLN / Magellan Health Inc
|
|
|
|
|
|
|
|
ACIU / AC Immune SA
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
ORGO / Organogenesis Holdings Inc.
|
|
|
|
|
|
|
|
MGTA / Magenta Therapeutics Inc
|
|
|
|
|
|
|
|
MGTX / MeiraGTx Holdings plc
|
|
|
|
|
|
|
|
APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
EHC / Encompass Health Corporation
|
|
|
|
|
|
|
|
AKU / Akumin Inc
|
|
|
|
|
|
|
|
AUPH / Aurinia Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
MTCR / Metacrine Inc
|
|
|
|
|
|
|
|
CARA / Cara Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc Call
|
|
|
|
|
|
|
|
QURE / uniQure N.V.
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
ONEM / 1life Healthcare Inc
|
|
|
|
|
|
|
|
APEN / Apollo Endosurgery Inc
|
|
|
|
|
|
|
|
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
BAX / Baxter International Inc.
|
|
|
|
|
|
|
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
PRQR / ProQR Therapeutics N.V.
|
|
|
|
|
|
|
|
ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
ADMA / ADMA Biologics, Inc.
|
|
|
|
|
|
|
|
CUE / Cue Biopharma, Inc.
|
|
|
|
|
|
|
|
KIDS / OrthoPediatrics Corp.
|
|
|
|
|
|
|
|
MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc Call
|
|
|
|
|
|
|
|
CNC / Centene Corporation
|
|
|
|
|
|
|
|
ZBH / Zimmer Biomet Holdings, Inc.
|
|
|
|
|
|
|
|
PRTA / Prothena Corporation plc
|
|
|
|
|
|
|
|